Caris LeVert, whose trade to the Indiana Pacers led to the discovery of his kidney cancer, is on pace to return to action in the season’s second half, The Athletic reported.
LeVert underwent surgery in January to treat renal cell carcinoma of his left kidney, discovered after the Pacers acquired him as part of the blockbuster trade that sent James Harden to Brooklyn.
“I hadn’t missed any games this season yet. I was feeling 100 percent healthy,” LeVert said at the time. “So, in a way, this trade definitely showed and revealed what was going on in my body, so I’m definitely looking at it from that side and definitely humbled to know that this trade could’ve possibly saved me in the long run.”
LeVert, 26, averaged 18.5 points, 6.0 assists and 4.3 rebounds in 12 games (four starts) this season with the Nets. The fifth-year pro had averages of 13.1 points, 3.7 assists and 3.7 rebounds in 225 career games (96 starts) with Brooklyn.
The Pacers enter play on Thursday with a 16-18 record, tied for ninth place in the Eastern Conference.
–Field Level Media